ACADIA Pharmaceuticals In...

NASDAQ: ACAD · Real-Time Price · USD
25.30
0.77 (3.14%)
At close: Aug 15, 2025, 3:59 PM
25.33
0.12%
After-hours: Aug 15, 2025, 05:36 PM EDT

ACADIA Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
26.67M 18.99M 143.74M 32.77M 33.39M 16.55M 45.8M -65.18M 1.11M -43.02M -41.73M -27.18M -34.01M -113.06M -43.09M -14.46M -43.87M -66.45M
Depreciation & Amortization
-1.16M 2.95M 5.21M -4.61M 2.57M 5.53M 1.64M 1.72M 1.77M 426K 489K 506K 515K 516K 535K 985K 929K 895K
Stock-Based Compensation
14.34M 11.38M 10.45M 26.16M 15.69M 14.75M 18.02M 18.54M 15.15M 14.71M 14.41M 18.31M 20.51M 14.96M 12.88M 15.55M 22M 13.18M
Other Working Capital
n/a 6.69M 31.95M 25.97M 12.23M 6.62M 39.36M 18.12M 7.96M 15.13M 10.02M -31K 2.78M 14.76M 11.84M -5.12M -9.99M 397K
Other Non-Cash Items
13.23M -2.12M -149.33M -21.72M 55.78M 36.61M 37.17M 46.59M -16.37M -6.61M -3.64M -5.19M 597K 108K -985K 207K 309K 544K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a -38.95M -50.07M 16.13M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
10.88M -10.88M 30.31M 30.65M -24.68M -5.97M 21.71M -10.56M -9.59M 16.56M 6.61M 10.98M -738K 21.14M 7.54M -19.34M -4.7M -8.32M
Operating Cash Flow
63.96M 20.32M 40.38M 63.25M 25.01M 29.08M 85.39M -58.95M 8.2M -17.93M -23.85M -727K -13.13M -76.33M -23.12M -17.06M -25.33M -60.15M
Capital Expenditures
98.54M -98.84M -453K -70K n/a n/a n/a -50K -40M n/a n/a n/a n/a n/a -1K n/a -45K -1.08M
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a 50K 40M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
-174.39M -156.01M -135.76M -151.49M -137.69M -80.15M -104.11M -37.2M -161.78M -66.89M -93.55M -144.25M -125.38M n/a -38.95M -251.32M -74.66M -127.86M
Sales Maturities Of Investments
131.39M 130.8M 111.85M 69.1M 81.5M 66.11M 103.76M 71.36M 7.5M 259.41M 75.8M 159.69M 69.58M 131.34M 110.5M 95M 57.5M 159.82M
Other Investing Acitivies
-98.84M n/a 146.51M n/a -56.19M -14.04M -347K -50K -40M 192.52M -17.75M 15.44M -55.8M 131.34M 71.55M -156.32M -17.16M 31.95M
Investing Cash Flow
-43.29M -124.05M 122.15M -82.46M -56.19M -14.04M -347K 34.11M -194.28M 192.52M -17.75M 15.44M -55.8M 131.34M 71.55M -156.32M -17.21M 30.88M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Financial Cash Flow
15.96M 1.84M 1.97M 268K 3.56M 1.04M 5.43M 12.75M 5.48M 1.47M 1.61M 287K 3.83M 2.47M 4.37M 1.07M 5M 7.73M
Net Cash Flow
36.64M -101.89M 164.44M -13.21M -27.61M 16.09M 90.46M -12.1M -180.6M 176.05M -40M 15.01M -65.09M 57.48M 52.8M -172.32M -37.53M -21.54M
Free Cash Flow
162.5M -78.52M 39.93M 63.18M 25.01M 29.08M 85.39M -59.01M -31.8M -17.93M -23.85M -727K -13.13M -76.33M -23.12M -17.06M -25.37M -61.23M